{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:10:19Z","timestamp":1779894619746,"version":"3.53.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6580,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1093\/annonc\/mdf010","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:59:57Z","timestamp":1027724397000},"page":"135-139","source":"Crossref","is-referenced-by-count":48,"title":["Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison ofhigh-dose conventional conditioning versusfludarabine-based reduced-intensity regimens"],"prefix":"10.1016","volume":"13","author":[{"given":"H.","family":"Bertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Illerhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf010_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/10428199909083388","article-title":"Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin\u2019s lymphoma: updated results of the Utrecht experience","volume":"34","author":"Verdonck","year":"1999","journal-title":"Leuk Lymph"},{"key":"10.1093\/annonc\/mdf010_bb0015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","article-title":"Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma","volume":"84","author":"Ratanatharathorn","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf010_bb0020","first-page":"1832","article-title":"Allogeneic bone marrow transplantation for low-grade lymphoma","volume":"92","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf010_bb0025","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.1993.11.12.2342","article-title":"Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin\u2019s disease: the 21-year Seattle experience","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf010_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1700614","article-title":"Bone marrow transplantation after failure of autologous transplant for non-Hodgkin\u2019s lymphoma","volume":"19","author":"de Lima","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdf010_bb0035","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1200\/JCO.1996.14.4.1291","article-title":"Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin\u2019s disease. European Group for Blood and Bone Marrow Transplantation","volume":"14","author":"Milpied","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf010_bb0040","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.1989.7.9.1288","article-title":"Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma","volume":"7","author":"Bearman","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf010_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1702512","article-title":"Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalane and allogeneic transplantation","volume":"26","author":"W\u00e4sch","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdf010_bb0050","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/sj.bmt.1700823","article-title":"Busulfan\/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment related toxicity","volume":"19","author":"Bertz","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdf010_bb0055","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2019s lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf010_bb0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1700781","article-title":"Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect","volume":"19","author":"van Besien","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdf010_bb0065","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bmt.1702392","article-title":"Allogeneic peripheral blood stem-cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma","volume":"25","author":"Nagler","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdf010_bb0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1008380527502","article-title":"Allogeneic hematopoetic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy","volume":"10","author":"Khouri","year":"1999","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419627626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419627626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/1\/135\/19479706\/135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:27:59Z","timestamp":1582183679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419627626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0923753419627626"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf010","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}